Beatriz Febrero Sánchez

11PUBLICATIONS
34CO-AUTHORS
Predictive and prognostic markersSystems physiologyCell physiologyNutrigenomics and personalised nutritionCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Aug 08, 2026
Predicting Structural Progression-Free Survival After Surgery for Medullary Thyroid Carcinoma.

|Aug 01, 2026
Is Calcitonin at 6-12 Months an Appropriate Criterion to Define Cure in Medullary Thyroid Carcinoma?

|May 28, 2026
Textbook outcome in surgery for primary hyperparathyroidism: first steps toward a composite quality metric.

|Feb 13, 2026
Symptomatic Pheochromocytoma: A Risk Model.

María Consuelo Muñoz, Beatriz Febrero, Miriam Abellán

|Mar 10, 2025
The Influence of the Clinical, Therapeutic and Socio-Personal Profile on the Quality of Life of Patients With Multiple Endocrine Neoplasia Type 1.

Beatriz Febrero, Esmeralda Teruel, Inmaculada Ros-Madrid

|Feb 25, 2025
Nutritional status and quality of life of patients with advanced gastroenteropancreatic neuroendocrine neoplasms in Spain: the NUTRIGETNE (GETNE-S2109) study.

Maribel Del Olmo-García, Lorena Hernandez-Rienda, Rocio Garcia-Carbonero

Pageof 2

Frequent Collaborators

2 joint publications

Juan José Ruiz-Manzanera

2 joint publications

Felicia Hanzu

1 joint publications

Javier Almela-Baeza

1 joint publications

Cristina Lamas